TOG Review (RCOG Journal)

MRCOG Part 2

Antenatal Care

Opioid misuse in pregnancy

Key Statistics

  • 55–95% — Infants showing signs of NAS
  • 60–120 mg — Methadone maintenance dose/day
  • 12–16 mg — Buprenorphine maintenance dose

Don't-miss facts

  1. NAS occurs in 55–95% of opioid-exposed infants; substitution therapy reduces but does not eliminate this risk

  2. Methadone 60–120 mg/day; buprenorphine 12–16 mg (up to 32 mg) maintenance – buprenorphine not first-line to initiate in pregnancy

  3. Never give naloxone to the neonate for respiratory depression – precipitates withdrawal crisis

  4. No sudden cessation in pregnancy; gradual 2nd-trimester detox = 2–3 mg methadone every 3–5 days

  5. Continue methadone/buprenorphine through labour – not sufficient analgesia alone; wait 2–8h after opioid analgesia before buprenorphine dosing

  6. Continuous CTG in labour – opioid effect (↓variability, low baseline, no accelerations) can mimic/mask hypoxia

  7. Promote LARC before discharge (failure rate <1%); avoid oxycodone/codeine postnatally (relapse/respiratory depression risk)

  8. Urinary opioid clearance 48–72h; infants monitored ≥72h with NAS scoring from 2h, 4-hourly

Substitution at a glance

Methadone: better retention, closer supervision for severe dependence

Buprenorphine: lower early overdose risk, milder withdrawal, less severe NAS – not first-line to initiate

Abbreviation Key

  • NAS — neonatal abstinence syndrome
  • IV — intravenous
  • CNS — central nervous system
  • IAPT — Improving Access to Psychological Therapies
  • DSM V — Diagnostic and Statistical Manual of Mental Disorders, 5th
  • SSRI — selective serotonin reuptake inhibitor edition
  • LARC — long-acting reversible contraception
  • NICE — National Institute for Health and Care Excellence
  • IUD — intrauterine device
  • CTG — cardiotocograph/cardiotocography
  • SCBU — special care baby unit
  • BBV — blood-borne virus
  • SIDS — sudden infant death syndrome
  • STI — sexually transmitted infection

Source: Thomson S et al. Opioid misuse in pregnancy. The Obstetrician & Gynaecologist 2022;24:101–108. doi:10.1111/tog.12779

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free